NCT03745716 2025-03-18
APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)
Aprea Therapeutics
Phase 3 Completed
Clinical Trials
4 trialsNCT06664970 2024-10-30
A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor
Peking Union Medical College Hospital
Phase 2 Enrolling by invitation
NCT06267898 2024-02-20
Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML
European Society for Blood and Marrow Transplantation
Completed
NCT05009537 2021-08-17
CARTOGEN
University Hospital, Brest
Recruiting